How 'killer' T cells could boost COVID immunity in face of new variants.Nature. 2021 02; 590(7846):374-375.Nat
Links
MeSH
Pub Type(s)
News
Language
eng
PubMed ID
33580217
Citation
Ledford, Heidi. "How 'killer' T Cells Could Boost COVID Immunity in Face of New Variants." Nature, vol. 590, no. 7846, 2021, pp. 374-375.
Ledford H. How 'killer' T cells could boost COVID immunity in face of new variants. Nature. 2021;590(7846):374-375.
Ledford, H. (2021). How 'killer' T cells could boost COVID immunity in face of new variants. Nature, 590(7846), 374-375. https://doi.org/10.1038/d41586-021-00367-7
Ledford H. How 'killer' T Cells Could Boost COVID Immunity in Face of New Variants. Nature. 2021;590(7846):374-375. PubMed PMID: 33580217.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - How 'killer' T cells could boost COVID immunity in face of new variants.
A1 - Ledford,Heidi,
PY - 2021/2/14/pubmed
PY - 2021/2/20/medline
PY - 2021/2/13/entrez
KW - Immunology
KW - SARS-CoV-2
KW - Vaccines
KW - Virology
SP - 374
EP - 375
JF - Nature
JO - Nature
VL - 590
IS - 7846
SN - 1476-4687
UR - https://www.unboundmedicine.com/medline/citation/33580217/How_'killer'_T_cells_could_boost_COVID_immunity_in_face_of_new_variants_
L2 - https://doi.org/10.1038/d41586-021-00367-7
DB - PRIME
DP - Unbound Medicine
ER -
Latest evidence on COVID-19 from PubMed, WHO, CDC.
Visit free Relief Central.
Visit free Relief Central.
Try the Free App:
